CTOs on the Move

Ulrich Medical Concepts

www.ulrichmedicalconcepts.com

 
Ulrich Medical Concepts is a Paducah, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Visiting Nurse and Community Health

Visiting Nurse and Community Health is a Arlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sterling Pharmaceutical Services

Sterling Pharmaceutical Services is a Maryville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Discount Development Svc

Discount Development Svc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedRisk

MedRisk is the leading provider of managed physical medicine for the workers` compensation industry and related market sectors. Unified through a uniquely integrated, US-based support model, we pride ourselves in combining clinical expertise with highly personal service and responsiveness. This focus allows us to offer distinct value to each stakeholder in the workers` comp process – carriers and TPAs, employers, adjusters and case managers, physicians, network providers and the patients themselves. In short, we`re here for you; at MedRisk, you`re never just a number – you`re an individual who deserves a solution tailored to your exact needs. We`re here to help you reach your goals and improve your outcomes – whatever they may be.

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.